In vitro and in vivo evaluation of recombinant silk-elastinlike hydrogels for cancer gene therapy

Journal of Controlled Release

Volumn 94, Issue 2-3, 2004, Pages 433-445

  Megeed, Zaki ^a,e   Haider, Mohamed ^a   Li, Daqing ^b,c   O'Malley Jr , Bert W ^b,c,f   Cappello, Joseph ^d   Ghandehari, Hamidreza ^a,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d Protein Polymer Technologies Inc   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adenoviral gene delivery; Cancer gene therapy; Controlled gene delivery; Genetically engineered polymers; Silk elastinlike protein polymers

Indexed keywords

DISEASE CONTROL; DNA; HYDROGELS; MOLECULAR WEIGHT; POLYMERS; PROTEINS; TUMORS;

TRANSFECTION;

GENE TRANSFER;

ELASTIN; GREEN FLUORESCENT PROTEIN; PLASMID DNA; POLYMER; SILK ELASTIN LIKE PROTEIN POLYMER; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER THERAPY; CHEMICAL STRUCTURE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DNA CONFORMATION; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; EVALUATION; FEMALE; GENE THERAPY; GENETIC TRANSFECTION; HYDROGEL; MICROENCAPSULATION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; STRUCTURE ANALYSIS;

EID: 1642441833     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2003.10.027     Document Type: Article

References (36)

1. Vile R.G., Russell S.J., Lemoine N.R. Cancer gene therapy: hard lessons and new courses. Gene Ther. 7:2000;2-8.
2. Truong-Le V.L., August J.T., Leong K.W. Controlled gene delivery by DNA-gelatin nanospheres. Hum. Gene Ther. 9:1998;1709-1717.
3. Gebrekidan S., Woo B.H., Deluca P.P. Formulation and in vitro transfection efficiency of poly (D,L-lactide-co-glycolide) microspheres containing plasmid DNA for gene delivery. AAPS Pharm. Sci. Tech. 1:2000;. (Article 28).
4. Luo D., Woodrow-Mumford K., Belcheva N., Saltzman W.M. Controlled DNA delivery systems. Pharm. Res. 16:1999;1300-1308.
5. Siemens D.R., Austin J.C., Hedican S.P., Tartaglia J., Ratliff T.L. Viral vector delivery in solid-state vehicles: gene expression in a murine prostate cancer model. J. Natl. Cancer Inst. 92:2000;403-412.
6. Chandler L.A., Doukas J., Gonzalez A.M., Hoganson D.K., Gu D.L., Ma C., Nesbit M., Crombleholme T.M., Herlyn M., Sosnowski B.A., Pierce G.F. FGF2-targeted adenovirus encoding platelet-derived growth factor-β enhances de novo tissue formation. Mol. Ther. 2:2000;153-160.
7. Doukas J., Chandler L.A., Gonzalez A.M., Gu D., Hoganson D.K., Ma C., Nguyen T., Printz M.A., Nesbit M., Herlyn M., Crombleholme T.M., Aukerman S.L., Sosnowski B.A., Pierce G.F. Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors. Hum. Gene Ther. 12:2001;783-798.
8. Urry D.W., Harris C.M., Luan C.X., Luan C.H., Channe-Gowda D., Parker T.M., Peng S.Q., Xu J. Park K. Controlled Drug Delivery: Challenges and Strategies. 1997;405-438 American Chemical Society, Washington, DC.
9. Cappello J., Crissman J., Dorman M., Mikolajczak M., Textor G., Marquet M., Ferrari F. Genetic engineering of structural protein polymers. Biotechnol. Prog. 6:1990;198-202.
10. 4ProGluGly elements. Macromolecules. 24:1991;1213-1214.
11. 19-VPGV, from Escherichia coli. Biotechnol. Prog. 8:1992;347-352.
12. Cappello J., Crissman J.W., Crissman M., Ferrari F.A., Textor G., Wallis O., Whitledge J.R., Zhou X., Burman D., Aukerman L., Stedronsky E.R. In-situ self-assembling protein polymer gel systems for administration, delivery, and release of drugs. J. Control. Release. 53:1998;105-117.
13. Nagarsekar A., Crissman J., Crissman M., Ferrari F., Cappello J., Ghandehari H. Genetic synthesis and characterization of pH- and temperature-sensitive silk-elastinlike protein block copolymers. J. Biomed. Mater. Res. 62:2002;195-203.
14. Nagarsekar A., Crissman J., Crissman M., Ferrari F., Cappello J., Ghandehari H. Genetic engineering of stimuli-sensitive silk-elastinlike protein block copolymers. Biomacromolecules. 4:2003;602-607.
15. Dinerman A.A., Cappello J., Ghandehari H., Hoag S.W. Swelling behavior of a genetically engineered silk-elastinlike protein polymer hydrogel. Biomaterials. 23:2002;4203-4210.
16. Dinerman A.A., Cappello J., Ghandehari H., Hoag S.W. Solute diffusion in genetically engineered silk-elastinlike protein polymer hydrogels. J. Control. Release. 82:2002;277-287.
17. Megeed Z., Cappello J., Ghandehari H. Controlled release of plasmid DNA from a genetically engineered silk-elastinlike hydrogel. Pharm. Res. 19:2002;954-959.
18. Megeed Z., Cappello J., Ghandehari H. Genetically engineered silk-elastinlike protein polymers for controlled drug delivery. Adv. Drug Deliv. Rev. 54:2002;1075-1091.
19. Cappello J. Domb A.J., Kost J., Wiseman D.M. Handbook of Biodegradable Polymers. 1997;387-416 Harwood Academic Publishers, Amsterdam.
20. Fu J.C., Hagemeir C., Moyer D.L. A unified mathematical model for diffusion from drug-polymer composite tablets. J. Biomed. Mater. Res. 10:1976;743-758.
21. Siepmann J., Ainaoui A., Vergnaud J.M., Bodmeier R. Calculation of the dimensions of drug-polymer devices based on diffusion parameters. J. Pharm. Sci. 87:1998;827-832.
22. Yang J. Walther W., Stein U. Gene Therapy of Cancer: Methods and Protocols. 2000;313-321 Humana Press, Totowa.
23. Bolton S. Pharmaceutical Statistics: Practical and Clinical Applications. 3rd ed. 1997;Marcel Dekker, New York.
24. Mendenhall W., Sincich T. Statistics for Engineering and the Sciences. 4th ed. 1995;Prentice Hall, Upper Saddle River, NJ.
25. Li D.Q., Duan L., Freimuth P., O'Malley B.W. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. Clin. Cancer Res. 5:1999;4175-4181.
26. Chen Z.Y., Yant S.R., He C.Y., Meuse L., Shen S., Kay M.A. Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver. Mol. Ther. 3:2001;403-410.
27. Bergan D., Galbraith T., Sloane D.L. Gene transfer in vitro and in vivo by cationic lipids is not significantly affected by levels of supercoiling of a reporter plasmid. Pharm. Res. 17:2000;967-973.
28. Gosnell D.L., Zimm B.H. Measurement of diffusion coefficients of DNA in agarose gel. Macromolecules. 26:1993;1304-1308.
29. Seils J., Dorfmuller T. Internal dynamics of linear and superhelical DNA as studied by photon correlation spectroscopy. Biopolymers. 31:1991;813-825.
30. Akerman B. Effects of supercoiling in electrophoretic trapping of circular DNA in polyacrylamide gels. Biophys. J. 74:1998;3140-3151.
31. Mickel S., Arena V. Jr., Bauer W. Physical properties and gel electrophoresis behavior of R12-derived plasmid DNAs. Nucleic Acids Res. 4:1977;1465-1482.
32. Nangia-Makker P., Hogan V., Honjo Y., Baccarini S., Tait L., Bresalier R., Raz A. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J. Natl. Cancer Inst. 94:2002;1854-1862.
33. Ruchelman A.L., Singh S.K., Wu X., Ray A., Yang J.M., Li T.K., Liu A., Liu L.F., LaVoie E.J. Diaza- and triazachrysenes: potent topoisomerase- targeting agents with exceptional antitumor activity against the human tumor xenograft, MDA-MB-435. Bioorg. Med. Chem. Lett. 12:2002;3333-3336.
34. Rubio N., Espana L., Fernandez Y., Blanco J., Sierra A. Metastatic behavior of human breast carcinomas overexpressing the Bcl-x(L) gene: a role in dormancy and organospecificity. Lab. Invest. 81:2001;725-734.
35. Lesoon-Wood A., Kim W.H., Kleinman H.K., Weintraub B.D., Mixson A.J. Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice. Hum. Gene Ther. 6:1995;395-405.
36. Lebedeva S., Bagdasarova S., Tyler T., Mu X., Wilson D.R., Gjerset R.A. Tumor suppression and therapy sensitization of localized and metastatic breast cancer by adenovirus p53. Hum. Gene Ther. 12:2001;763-772.